• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

(ADP - 核糖)n参与DNA切除修复。

(ADP-ribose)n participates in DNA excision repair.

作者信息

Durkacz B W, Omidiji O, Gray D A, Shall S

出版信息

Nature. 1980 Feb 7;283(5747):593-6. doi: 10.1038/283593a0.

DOI:10.1038/283593a0
PMID:6243744
Abstract

Chromatin proteins are covalently modified by at least five different processes; in no case has the precise physiological function been established. One of these post-synthetic, covalent modifications is effected by the enzyme poly(ADP-ribose) polymerase, which uses the coenzyme NAD+ to ADP-ribosylate chromatin proteins. The modification consists largely of mono(ADP-ribose), but long, homopolymer chains of (ADP-ribose) are also present. Various physiological functions have been suggested for (ADP-ribose)n. Here we demonstrate that one function of (ADP-ribose)n is to participate in the cellular recovery from DNA damage. Specific inhibitors of poly(ADP-ribose) polymerase prevent rejoining of DNA strand breaks caused by dimethyl sulphate and cytotoxicity is enhanced thereby. The rejoining of strand breaks is prevented also by nutritionally depleting the cells of NAD.

摘要

染色质蛋白通过至少五种不同的过程进行共价修饰;在任何情况下,其精确的生理功能都尚未确定。这些合成后共价修饰中的一种是由聚(ADP - 核糖)聚合酶催化的,该酶利用辅酶NAD⁺对染色质蛋白进行ADP - 核糖基化。这种修饰主要由单(ADP - 核糖)组成,但也存在长的(ADP - 核糖)同聚物链。对于(ADP - 核糖)ₙ已经提出了各种生理功能。在这里我们证明(ADP - 核糖)ₙ的一个功能是参与细胞从DNA损伤中的恢复。聚(ADP - 核糖)聚合酶的特异性抑制剂可阻止由硫酸二甲酯引起的DNA链断裂的重新连接,从而增强细胞毒性。通过营养耗尽细胞中的NAD也可阻止链断裂的重新连接。

相似文献

1
(ADP-ribose)n participates in DNA excision repair.(ADP - 核糖)n参与DNA切除修复。
Nature. 1980 Feb 7;283(5747):593-6. doi: 10.1038/283593a0.
2
Acceptors for the poly ADP-ribosylation modification of chromatin structure are altered by carcinogen-induced DNA damage.致癌物诱导的DNA损伤会改变染色质结构聚ADP核糖基化修饰的受体。
Carcinogenesis. 1982;3(10):1143-8. doi: 10.1093/carcin/3.10.1143.
3
ADP-ribosylation reactions.ADP-核糖基化反应
Curr Top Cell Regul. 1982;21:175-87. doi: 10.1016/b978-0-12-152821-8.50011-6.
4
DNA fragmentation and NAD depletion. Their relation to the turnover of endogenous mono(ADP-ribosyl) and poly(ADP-ribosyl) proteins.DNA片段化与NAD耗竭。它们与内源性单(ADP-核糖基)和多(ADP-核糖基)蛋白周转的关系。
J Biol Chem. 1982 Nov 10;257(21):12872-7.
5
Poly(ADP-ribosylation) reduces the steady-state level of breaks in DNA following treatment of human cells with alkylating agents.
Carcinogenesis. 1984 Jan;5(1):117-9. doi: 10.1093/carcin/5.1.117.
6
Mono- and poly(ADP-ribose) metabolism following DNA damage.DNA损伤后的单(ADP-核糖)和多(ADP-核糖)代谢
Princess Takamatsu Symp. 1983;13:165-74.
7
Multiple autopoly(ADP-ribosyl)ation of rat liver poly(ADP-ribose) synthetase. Mode of modification and properties of automodified synthetase.大鼠肝脏多聚(ADP-核糖)合成酶的多重自动多聚(ADP-核糖基)化。自动修饰合成酶的修饰模式及特性
J Biol Chem. 1981 Sep 25;256(18):9483-9.
8
Poly (ADP-ribose) is not involved in the rejoining of DNA breaks accumulated to high levels in u.v.-irradiated HeLa cells.聚(ADP-核糖)不参与紫外线照射的HeLa细胞中积累到高水平的DNA断裂的重新连接。
Carcinogenesis. 1985 Jul;6(7):1033-6. doi: 10.1093/carcin/6.7.1033.
9
Cellular regulation of poly(ADP) ribosylation of proteins. I. Comparison of hepatocytes, cultured cells and liver nuclei and the influence of varying concentrations of NAD.蛋白质多聚(ADP)核糖基化的细胞调控。I. 肝细胞、培养细胞和肝细胞核的比较以及不同浓度NAD的影响。
Exp Cell Res. 1985 Nov;161(1):41-52. doi: 10.1016/0014-4827(85)90488-4.
10
Poly(ADP-ribose) may signal changing metabolic conditions to the chromatin of mammalian cells.聚(ADP - 核糖)可能会向哺乳动物细胞的染色质发出代谢条件变化的信号。
Proc Natl Acad Sci U S A. 1987 Mar;84(5):1286-9. doi: 10.1073/pnas.84.5.1286.

引用本文的文献

1
Unveiling the mechanism of Pogostemon cablin (Blanco) Benth in treating heat illnesses via network pharmacology and molecular simulation.基于网络药理学和分子模拟揭示广藿香治疗热病的作用机制
PLoS One. 2025 Sep 8;20(9):e0331401. doi: 10.1371/journal.pone.0331401. eCollection 2025.
2
Synthetic Lethality-Based Targets and Their Exploration in Tumour Combination Strategies.基于合成致死性的靶点及其在肿瘤联合治疗策略中的探索
J Cell Mol Med. 2025 Aug;29(16):e70756. doi: 10.1111/jcmm.70756.
3
A comprehensive review of immunotherapy in gastrointestinal tumors with a focus on the role of combination therapy with PARP inhibitors.
胃肠道肿瘤免疫治疗的全面综述,重点关注与PARP抑制剂联合治疗的作用。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun 9. doi: 10.1007/s00210-025-04336-z.
4
The clinically applied PARP inhibitor talazoparib ameliorates imiquimod-induced psoriasis in mice without reducing skin inflammation.临床应用的聚(ADP-核糖)聚合酶(PARP)抑制剂他拉唑帕尼可改善咪喹莫特诱导的小鼠银屑病,且不减轻皮肤炎症。
Front Pharmacol. 2025 Feb 19;16:1519066. doi: 10.3389/fphar.2025.1519066. eCollection 2025.
5
Single-molecule analysis of PARP1-G-quadruplex interaction.聚(ADP-核糖)聚合酶1(PARP1)与G-四链体相互作用的单分子分析
bioRxiv. 2025 Jan 8:2025.01.06.631587. doi: 10.1101/2025.01.06.631587.
6
DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications.癌症治疗中的DNA损伤反应抑制剂:过去的经验教训、现状与未来启示
Nat Rev Drug Discov. 2025 Jan;24(1):19-39. doi: 10.1038/s41573-024-01060-w. Epub 2024 Nov 12.
7
Nonrepair functions of DNA mismatch repair proteins: new avenues for precision oncology.DNA错配修复蛋白的非修复功能:精准肿瘤学的新途径
Trends Cancer. 2025 Jan;11(1):49-61. doi: 10.1016/j.trecan.2024.10.001. Epub 2024 Oct 28.
8
Poly(ADP-Ribose) Polymerase (PARP) Inhibitors for Cancer Therapy: Advances, Challenges, and Future Directions.聚(ADP-核糖)聚合酶(PARP)抑制剂在癌症治疗中的应用:进展、挑战与未来方向。
Biomolecules. 2024 Oct 9;14(10):1269. doi: 10.3390/biom14101269.
9
Glycolysis: A multifaceted metabolic pathway and signaling hub.糖酵解:一条多方面的代谢途径和信号枢纽。
J Biol Chem. 2024 Nov;300(11):107906. doi: 10.1016/j.jbc.2024.107906. Epub 2024 Oct 22.
10
Fertility protection during chemotherapy treatment by boosting the NAD(P) metabolome.通过增强 NAD(P)代谢组来保护化疗期间的生育能力。
EMBO Mol Med. 2024 Oct;16(10):2583-2618. doi: 10.1038/s44321-024-00119-w. Epub 2024 Aug 21.